Publication | Closed Access

Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine and an MF59-adjuvanted influenza vaccine after concomitant vaccination in ⩾60-year-old adults

VaccinologyVaccine SafetyVaccination⩾60-Year-old AdultsMedicineVaccine SurveillanceImmunologyConcomitant VaccinationVaccine EfficacyInfluenza VaccineInfection ControlMf59-adjuvanted Influenza VaccineVaccine ResearchInfluenza Vaccines